MBX
Price:
$30.54
Market Cap:
$1.03B
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial designed as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developi...[Read more]
Industry
Biotechnology
IPO Date
2000-01-14
Stock Exchange
NASDAQ
Ticker
MBX
According to MBX Biosciences, Inc. Common Stock’s latest financial reports and current stock price. The company's current ROE is -29.28%. This represents a change of 282.38% compared to the average of -7.66% of the last 4 quarters.
The mean historical ROE of MBX Biosciences, Inc. Common Stock over the last ten years is 27.41%. The current -29.28% ROE has changed -206.83% with respect to the historical average. Over the past ten years (40 quarters), MBX's ROE was at its highest in in the June 2024 quarter at 16.20%. The ROE was at its lowest in in the March 2024 quarter at -17.80%.
Average
27.41%
Median
44.93%
Minimum
-24.05%
Maximum
61.34%
Discovering the peaks and valleys of MBX Biosciences, Inc. Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 61.34%
Minimum Annual Increase = -153.53%
Minimum Annual ROE = -24.05%
| Year | ROE | Change |
|---|---|---|
| 2024 | -24.05% | -153.53% |
| 2023 | 44.93% | -26.75% |
The current ROE of MBX Biosciences, Inc. Common Stock (MBX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
27.41%
5-year avg
27.41%
10-year avg
27.41%
MBX Biosciences, Inc. Common Stock’s ROE is greater than MeiraGTx Holdings plc (-1065.47%), greater than Replimune Group, Inc. (-69.34%), greater than ArriVent BioPharma, Inc. Common Stock (-55.48%), greater than Ginkgo Bioworks Holdings, Inc. (-53.55%), greater than Iovance Biotherapeutics, Inc. (-52.87%), greater than MoonLake Immunotherapeutics (-41.61%), greater than Astria Therapeutics, Inc. (-38.63%), greater than Erasca, Inc. (-31.19%), greater than REGENXBIO Inc. (-78.29%), greater than Verastem, Inc. (-9587.28%),
| Company | ROE | Market cap |
|---|---|---|
| -1065.47% | $692.22M | |
| -69.34% | $825.97M | |
| -55.48% | $1.01B | |
| -53.55% | $503.29M | |
| -52.87% | $729.72M | |
| -41.61% | $955.18M | |
| -38.63% | $748.95M | |
| -31.19% | $905.04M | |
| -78.29% | $657.04M | |
| -9587.28% | $641.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MBX Biosciences, Inc. Common Stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MBX Biosciences, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is MBX Biosciences, Inc. Common Stock's ROE?
How is the ROE calculated for MBX Biosciences, Inc. Common Stock (MBX)?
What is the highest ROE for MBX Biosciences, Inc. Common Stock (MBX)?
What is the 3-year average ROE for MBX Biosciences, Inc. Common Stock (MBX)?
What is the 5-year average ROE for MBX Biosciences, Inc. Common Stock (MBX)?
How does the current ROE for MBX Biosciences, Inc. Common Stock (MBX) compare to its historical average?